SCHEMBL10135655

SCHEMBL10135655

CC[C@@H]1CNCCCN1Cc1ccc2cnccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 3/20 0.44
CYP19A1 P11511 2/20 0.43
PRKCZ Q05513 1/20 0.40
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 2/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TBXAS1 P24557 1/20 0.38
HRH3 Q9Y5N1 2/20 0.36
ROCK2 O75116 1/20 0.36
PARP1 P09874 1/20 0.35
PDE2A O00408 1/20 0.35
IKBKB O14920 3/20 0.35
CHUK O15111 2/20 0.35
PDE10A Q9Y233 1/20 0.34
CXCR4 P61073 1/20 0.34
CHRM2 P08172 1/20 0.34
PIM1 P11309 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10135688 0.89 ROCK1 (0.44) ROCK1CYP19A1PRKCZTBXAS1HRH3
SCHEMBL10135624 0.86 ROCK1 (0.46) ROCK1CYP19A1PRKCZMAPK1ALDH1A1
SCHEMBL10135637 0.86 ROCK1 (0.46) ROCK1CYP19A1PRKCZMAPK1ALDH1A1
SCHEMBL10135694 0.86 ROCK1 (0.43) ROCK1CYP19A1PRKCZALDH1A1SMN1; SMN2
SCHEMBL10135871 0.84 ROCK1 (0.40) ROCK1CYP19A1PRKCZTBXAS1ROCK2
SCHEMBL10135677 0.83 ROCK1 (0.45) ROCK1CYP19A1PRKCZMAPK1ALDH1A1
SCHEMBL10135701 0.82 ROCK1 (0.44) ROCK1CYP19A1PRKCZMAPK1ALDH1A1
SCHEMBL10135734 0.82 ROCK1 (0.44) ROCK1CYP19A1PRKCZMAPK1ALDH1A1
SCHEMBL10135774 0.81 HRH3 (0.44) ROCK1CYP19A1PRKCZALDH1A1HRH3
SCHEMBL10135790 0.81 HRH3 (0.44) ROCK1CYP19A1PRKCZALDH1A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951997-B2 Substituted isoquinoline derivative D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) 2015-02-10 US disclosed
US-20120035159-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035159-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE SULT1A1, SULT1E1, SULT2A1 ROCK1 1837/4885CYP19A1 2996/4885PRKCZ 3050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.